Trading Tips Blog

The weight-loss drug wars just got a lot more interesting. Structure Therapeutics — a biotech most traders have never heard of — just dropped phase 2 data showing its oral GLP-1 drug can match the results of injectable blockbusters like Ozempic and Mounjaro. The stock jumped 8% in premarket on the news. The numbers are remarkable. Aleniglipron, Structure's oral pill, delivered placebo-adjusted weight loss of 16.3% at 180mg and 16.0% at 240mg over 44 weeks — with no evidence of a ...
Read More About This

While the S&P 500 is basically flat this year and tech stocks are getting smacked around, one sector has been quietly running circles around the market: defence. The Morningstar Global Aerospace and Defense Index is up 11.7% year-to-date. The broader global stock market? Up 0.4%. That's not a gap — that's a canyon. And the Iran conflict is only making it wider. Here's what's driving the move. Europe is scrambling to rearm after decades of letting the U.S. foot the bill. Germany ...
Read More About This

Mark Zuckerberg is about to make the biggest bet of his career — and he's funding it by firing 20% of his company. Reuters reported Friday that Meta is planning sweeping layoffs that could affect 15,000 or more employees, making it the largest headcount reduction in the company's history. The goal? Free up cash to pour into a staggering $600 billion data center buildout by 2028 and compete head-on with Google, Microsoft, and OpenAI in the generative AI arms race. The timing ...
Read More About This

If you've been paying attention to the stock market, you've probably noticed that Applied Digital (NASDAQ:APLD) is having the kind of year that makes other investors weep into their portfolios. Up 255% year-to-date? Yeah, that's not a typo. And just when you thought the party might be slowing down, the company announced a financing deal that sent the stock soaring another 14% to over $27 per share. Here's the thing: this isn't some meme stock fueled by Reddit threads and FOMO ...
Read More About This

Here's a fun fact nobody wants to hear: JPMorgan just warned that if oil stays above $90 a barrel, the S&P 500 could take a 15% nosedive. And it's not just about paying more at the pump—it's a whole domino effect that could wreck your wealth on paper. Let's break down what's happening. Brent crude has been hovering around $100 a barrel thanks to Middle East supply disruptions. JPMorgan's researchers are basically saying: "Yeah, this could get messy." If oil stays ...
Read More About This

Here's the thing about the AI boom: it's not one race. It's a relay race where each leg creates a new set of winners. First, everyone needed GPUs—Nvidia won that round so hard it became a verb. Then hyperscalers realized they needed servers to hold all those GPUs. Then they hit a thermal wall and suddenly liquid cooling companies were printing money. Then the power grid started sweating. Then memory became the constraint. Now? The bottleneck is hiding inside the data center ...
Read More About This

Everyone’s watching crude oil. It’s the obvious play — Brent spiked to $120, the Strait of Hormuz is a chokepoint nightmare, and energy traders are having their best month in years. But the quieter, potentially bigger trade is happening in natural gas. And the United States is sitting on a gold mine. When Qatar declared force majeure on its gas exports — effectively pulling 20% of the world’s LNG supply offline overnight — it sent shockwaves through energy markets that most ...
Read More About This

Nobody rings a bell at the top. But right now, the market is doing something close — it’s flashing three distinct warning signals that weren’t present just eight weeks ago. The probability of a significant crash hasn’t been this elevated since the early days of 2020, and investors who ignore it do so at their own risk. Warning number one: the geopolitical wildcard. The U.S.-Israel attack on Iran and Iran’s subsequent attempt to block the Strait of Hormuz — through which ...
Read More About This